Delivery Order SPE2DB25D2204-SPE2DB25FTGAK
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,996.76 delivery order contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication. The contract has a firm fixed-price pricing type and an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,968.32 firm fixed price delivery order is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a critical pharmaceutical product. The contract has a completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.92 firm fixed-price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,381.11 delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of 4,567,279,694 units of RIFAMPIN 300 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract, valued at $4,791.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 60 capsules of 300 mg Rifampin. The single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs...
This federal contract award, valued at $14,375.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,222,276 units of RIFAMPIN 300 MG CAPSULE 30S, with a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,133,489 units of rifampin 300 mg capsules. The contract, valued at $1,098.31, has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. The contract is a delivery order with a firm fixed-price pricing type, issued by the Defense agency Medical Supply Chain. Amerisourcebergen, a major pharmaceutical distribution company, does not have a set-aside designation...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $27,852.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The $2,289.52 firm fixed-price delivery order has a completion date of May 23, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...